ENGN compared with OM: revenue, margins and what each company keeps, and the suppliers and customers both name

ENGNenGene Therapeutics Inc.

Mkt capRevenueRevenue

OMOutset Medical, Inc.

Mkt capRevenueRevenue

Compare

ENGNenGene Therapeutics Inc.

OMOutset Medical, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

ENGN: latest quarter not drawable. OM: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ENGN 0

None

Shared 0

No disclosed counterparties: ENGN.

Only OM 1

—Tacnaunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

ENGN, solidOM, dashed

ENGNenGene Therapeutics Inc.

1.50▼−1.86%· post 1.50

Mkt cap$102.5MRevenue—Revenue—

OMOutset Medical, Inc.

3.93▼−6.21%· post 3.93

ClosedOct 30 '26

Mkt cap$75.8MRevenue$32MQ2 FY26Revenue$119MFY25

Compare

ClosedOct 30 '26

ENGNenGene Therapeutics Inc.

OMOutset Medical, Inc.

1.50▼−1.86%post 1.50

Price

3.93▼−6.21%post 3.93

$102.5M

Mkt cap

$75.8M

—

Revenue

$32MQ2 FY26

—

Revenue

$119MFY25

ENGN1.50▼−1.86%vsOM3.93▼−6.21%ClosedOct 30 '26